Wang Yunlan, Tao Zijia, Cheng Ying, Wang Shaokun, Yi Dehui
The Department of Organ Transplantation and Hepatobiliary Surgery, The First Hospital of China Medical University, Shenyang, 110000, China.
Department of Interventional Radiology, the First Hospital of China Medical University, Shenyang, 110000, China.
Discov Oncol. 2025 Jun 12;16(1):1065. doi: 10.1007/s12672-025-02805-8.
Hepatocellular carcinoma (HCC) currently poses a formidable threat to human life and health, and an observable increase in the number of deaths is evident year by year. Currently, surgical resection stands as the foremost treatment modality; however, recurrence remains a persistent challenge, posing a significant barrier to the long-term prognosis for individuals diagnosed with HCC. Studies indicated that the risk of HCC may be influenced by inflammatory proteins and immune cells, but the associations between inflammatory proteins, immune cells, and HCC remained unclear.
The investigation integrated data from 731 types of circulating immune cells and 91 inflammatory proteins, alongside a cohort involving 456,348 participants (comprising 456,220 controls and 128 cases) sourced from genome-wide association studies (GWAS). The principal objective of our research was to assess the potential causal association between inflammatory proteins and HCC by bidirectional univariate MR (UVMR) analysis. Furthermore, the total genetic prediction effect of immune cells-mediating inflammatory proteins on the likelihood of developing HCC was investigated by a two-step multivariable MR (MVMR).
Our results indicated that 2-positive inflammatory proteins (IL-17A and TNF-β) suggest a potential causal relationship on HCC, and HCC could affect FGF-21 by bidirectional UVMR analysis. Additionally, four immune cell types (CD25 on IgD+ CD38dim B cells, CD4 on CD39+ secreting CD4 regulatory T cells, CD25 on B cells, and CD25 on IgD+ B cells) exhibited an inverse relationship with the risk of HCC. Moreover, two inflammatory proteins demonstrated dual effects on HCC risk through modulation-either decreasing or increasing-the aforementioned four immune cell types, each with varying proportions of mediation effects as analyzed through two-step mediation MR analysis.
This study revealed the potential causality between inflammatory proteins, immune cells, and HCC risk by MR analyses, which may potentially offer a deeper comprehension for the risk of HCC and the interaction between inflammatory proteins, immune cells and HCC and may help to seek new biomarkers for predicting the likelihood of developing HCC.
肝细胞癌(HCC)目前对人类生命和健康构成巨大威胁,且死亡人数逐年显著增加。目前,手术切除是首要的治疗方式;然而,复发仍然是一个持续存在的挑战,对被诊断为HCC的个体的长期预后构成重大障碍。研究表明,HCC的风险可能受炎症蛋白和免疫细胞影响,但炎症蛋白、免疫细胞与HCC之间的关联仍不明确。
该研究整合了来自731种循环免疫细胞和91种炎症蛋白的数据,以及一个来自全基因组关联研究(GWAS)的队列,该队列涉及456,348名参与者(包括456,220名对照和128例病例)。我们研究的主要目的是通过双向单变量孟德尔随机化(UVMR)分析评估炎症蛋白与HCC之间的潜在因果关联。此外,通过两步多变量孟德尔随机化(MVMR)研究免疫细胞介导的炎症蛋白对发生HCC可能性的总遗传预测效应。
我们的结果表明,两种阳性炎症蛋白(IL-17A和TNF-β)提示与HCC存在潜在因果关系,并且通过双向UVMR分析发现HCC可影响FGF-21。此外,四种免疫细胞类型(IgD + CD38dim B细胞上的CD25、CD39 + 分泌CD4调节性T细胞上的CD4、B细胞上的CD25以及IgD + B细胞上的CD25)与HCC风险呈负相关。此外,两种炎症蛋白通过调节上述四种免疫细胞类型(减少或增加)对HCC风险表现出双重作用,通过两步中介孟德尔随机化分析,每种作用具有不同比例的中介效应。
本研究通过孟德尔随机化分析揭示了炎症蛋白、免疫细胞与HCC风险之间的潜在因果关系,这可能有助于更深入地理解HCC风险以及炎症蛋白、免疫细胞与HCC之间的相互作用,并可能有助于寻找预测发生HCC可能性的新生物标志物。